TY - JOUR
T1 - Fighting Cancer around the World
T2 - A Framework for Action
AU - Horgan, Denis
AU - Mia, Rizwana
AU - Erhabor, Tosan
AU - Hamdi, Yosr
AU - Dandara, Collet
AU - Lal, Jonathan A.
AU - Domgue, Joel Fokom
AU - Ewumi, Oladimeji
AU - Nyawira, Teresia
AU - Meyer, Salomé
AU - Kondji, Dominique
AU - Francisco, Ngiambudulu M.
AU - Ikeda, Sadakatsu
AU - Chuah, Chai
AU - De Guzman, Roselle
AU - Paul, Anupriya
AU - Reddy Nallamalla, Krishna
AU - Park, Woong Yang
AU - Tripathi, Vijay
AU - Tripathi, Ravikant
AU - Johns, Amber
AU - Singh, Mohan P.
AU - Phipps, Maude E.
AU - Dube, France
AU - Whittaker, Kate
AU - Mukherji, Deborah
AU - Rasheed, Hadi Mohamad Abu
AU - Kozaric, Marta
AU - Pinto, Joseph A.
AU - Doral Stefani, Stephen
AU - Augustovski, Federico
AU - Aponte Rueda, Maria Eugenia
AU - Fujita Alarcon, Ricardo
AU - Barrera-Saldana, Hugo A.
N1 - Funding Information:
Funding: This research received a grant from PROMISE-Personalized Medicine Inquiry-Based Education co-funded by the Erasmus+ Programme of the European Union; Grant Agreement No.: 2019-1-HR01-KA203-061010.
Funding Information:
This research received a grant from PROMISE- Personalized Medicine Inquiry-Based Education co-funded by the Erasmus+ Programme of the European Union; Grant Agreement No.: 2019-1-HR01-KA203-061010.
Publisher Copyright:
© 2022 by the authors.
PY - 2022/11
Y1 - 2022/11
N2 - Tackling cancer is a major challenge right on the global level. Europe is only the tip of an iceberg of cancer around the world. Prosperous developed countries share the same problems besetting Europe–and the countries and regions with fewer resources and less propitious conditions are in many cases struggling often heroically against a growing tide of disease. This paper offers a view on these geographically wider, but essentially similar, challenges, and on the prospects for and barriers to better results in this ceaseless battle. A series of panels have been organized by the European Alliance for Personalised Medicine (EAPM) to identify different aspects of cancer care around the globe. There is significant diversity in key issues such as NGS, RWE, molecular diagnostics, and reimbursement in different regions. In all, it leads to disparities in access and diagnostics, patients’ engagement, and efforts for a better understanding of cancer.
AB - Tackling cancer is a major challenge right on the global level. Europe is only the tip of an iceberg of cancer around the world. Prosperous developed countries share the same problems besetting Europe–and the countries and regions with fewer resources and less propitious conditions are in many cases struggling often heroically against a growing tide of disease. This paper offers a view on these geographically wider, but essentially similar, challenges, and on the prospects for and barriers to better results in this ceaseless battle. A series of panels have been organized by the European Alliance for Personalised Medicine (EAPM) to identify different aspects of cancer care around the globe. There is significant diversity in key issues such as NGS, RWE, molecular diagnostics, and reimbursement in different regions. In all, it leads to disparities in access and diagnostics, patients’ engagement, and efforts for a better understanding of cancer.
KW - cancer
KW - diagnostics
KW - genomics
KW - global
KW - health care
KW - liquid biopsy
KW - next-generation sequencing
KW - patients
KW - personalized medicine
KW - policy framework
KW - reimbursement
UR - http://www.scopus.com/inward/record.url?scp=85141850023&partnerID=8YFLogxK
U2 - 10.3390/healthcare10112125
DO - 10.3390/healthcare10112125
M3 - Article
C2 - 36360466
AN - SCOPUS:85141850023
SN - 2227-9032
VL - 10
JO - Healthcare
JF - Healthcare
IS - 11
M1 - 2125
ER -
